Patent classifications
A61M3/00
CONTAINER WITH LOW PARTICULATE EMISSION AND FRICTION CONTROLLED DRY SLIDING SURFACE AND METHODS FOR PRODUCING SAME
A container is provided that includes a container body with an outer surface and an inner surface. The inner surface contains silicon oxide and the silicon oxide containing inner surface is at least partially modified with a fluorine containing compound. The fluorine containing compound is chemically bonded to the silicon oxide of the container body via at least one SiOSi bond.
CONTAINER WITH LOW PARTICULATE EMISSION AND FRICTION CONTROLLED DRY SLIDING SURFACE AND METHODS FOR PRODUCING SAME
A container is provided that includes a container body with an outer surface and an inner surface. The inner surface contains silicon oxide and the silicon oxide containing inner surface is at least partially modified with a fluorine containing compound. The fluorine containing compound is chemically bonded to the silicon oxide of the container body via at least one SiOSi bond.
Device and method for preparing and administering one-component fibrin sealant
Provided herein are systems for preparing and delivering fibrin sealant to a surface and methods of use thereof. In one embodiment, the system comprises: a. a quantity of a liquid mixture disposed within a container, the mixture comprising: I. fibrin or II. fibrinogen and Factor II; and b. a resin bed disposed within a vessel, the vessel capable of being in fluid communication with the container, wherein when in fluid communication, passage of the mixture through the vessel results in modification of the concentration of small molecules inhibitor(s) and/or inducer(s) within the mixture, favoring fibrin clot formation.
DEVICE AND METHOD FOR PREPARING AND ADMINISTERING ONE-COMPONENT FIBRIN SEALANT
Provided herein are systems for preparing and delivering fibrin sealant to a surface and methods of use thereof. In one embodiment, the system comprises: a. a quantity of a liquid mixture disposed within a container, the mixture comprising: I. fibrin or II. fibrinogen and Factor II; and b. a resin bed disposed within a vessel, the vessel capable of being in fluid communication with the container, wherein when in fluid communication, passage of the mixture through the vessel results in modification of the concentration of small molecules inhibitor(s) and/or inducer(s) within the mixture, favoring fibrin clot formation.
IRRIGATION DEVICES, METHODS, AND SYSTEMS
Irrigation devices, methods, and systems are disclosed. The system comprises a catheter with one or more lumens and an expandable portion. One or more pumps are used to supply a mixture of contrasting and dilating agents in an interior kidney volume and flush a portion of the mixture out of the interior kidney volume. The method comprises placing a catheter into the interior kidney volume through a ureter, occluding a portion of the ureter with a distal end of the catheter, forming an exit port through an exterior kidney surface, flowing the contrasting and dilating agents through the one or more lumens to supply the mixture in the interior kidney volume, and flushing a portion of the mixture out of the exit port.
Trocar Sleeve
A trocar sleeve that isolates the surgical device or movement thereof to inhibit or prevent an established non-jet streaming condition from becoming a jet streaming condition and a method of inhibiting or preventing a jet streaming condition from occurring due to instrument obstruction.
Device and method for preparing and administering one-component fibrin sealant
Provided herein are systems for preparing and delivering fibrin sealant to a surface and methods of use thereof. In one embodiment, the system comprises: a. a quantity of a liquid mixture disposed within a container, the mixture comprising: I. fibrin or II. fibrinogen and Factor II; and b. a resin bed disposed within a vessel, the vessel capable of being in fluid communication with the container, wherein when in fluid communication, passage of the mixture through the vessel results in modification of the concentration of small molecules inhibitor(s) and/or inducer(s) within the mixture, favoring fibrin clot formation.
COMPOSITIONS COMPRISING RELAXIN AND METHODS OF USE THEREOF
The present invention provides methods for treating a stiffened joint in a subject that comprise administering relaxin, e.g., a PEGylated relaxin-2, to the subject. The relaxin may be administered intra-articularly as a sustained release formulation. The present invention also provides sustained release formulations in the form of a hydrogel for administering polypeptides that are covalently attached to a polymer, e.g., PEG.
Container with low particulate emission and friction controlled dry sliding surface and methods for producing same
The invention relates to a container comprising a container body having an outer surface and an inner surface, wherein the inner surface contains silicon oxide; and the silicon oxide containing inner surface is at least partially modified with a fluorine containing compound, wherein the fluorine containing compound is chemically bonded to the silicon oxide of the container body via at least one SiOSi bond.
Container with low particulate emission and friction controlled dry sliding surface and methods for producing same
The invention relates to a container comprising a container body having an outer surface and an inner surface, wherein the inner surface contains silicon oxide; and the silicon oxide containing inner surface is at least partially modified with a fluorine containing compound, wherein the fluorine containing compound is chemically bonded to the silicon oxide of the container body via at least one SiOSi bond.